SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2016–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	5	1
2019	—	4	1
2018	—	4	1
2017	—	2	1
2016	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AKIN GUMP STRAUSS HAUER FELD	—	41

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	37
SENATE	37
White House Office	18
Centers For Medicare and Medicaid Services (CMS)	17
Health & Human Services, Dept of (HHS)	16
Commerce, Dept of (DOC)	8
U.S. Trade Representative (USTR)	7
Natl Economic Council (NEC)	5
Food & Drug Administration (FDA)	3
Treasury, Dept of	3
Office of Science & Technology Policy (OSTP)	2
Patent & Trademark Office (PTO)	2
State, Dept of (DOS)	2
Office of Management & Budget (OMB)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	27
Health Issues	Health Issues	27
Medicare/Medicaid	Medicare/Medicaid	23
Budget/Appropriations	Budget/Appropriations	9
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	7
Copyright/Patent/Trademark	Copyright/Patent/Trademark	6
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 6197119th Congress

Health Tech Investment Act

2026 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.

Client expense: — · Firm income: $70,000

Matched citations: H.R. 6197

S. 1399119th Congress

Health Tech Investment Act

2026 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.

Client expense: — · Firm income: $70,000

Matched citations: S. 1399

H.R. 6197119th Congress

Health Tech Investment Act

2026 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.

Client expense: — · Firm income: $70,000

Matched citations: H.R. 6197

S. 1399119th Congress

Health Tech Investment Act

2026 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.

Client expense: — · Firm income: $70,000

Matched citations: S. 1399

Show 21 more cited filings

H.R. 6197119th Congress

Health Tech Investment Act

2026 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act.

Client expense: — · Firm income: $70,000

Matched citations: H.R. 6197

S. 1399119th Congress

Health Tech Investment Act

2026 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act.

Client expense: — · Firm income: $70,000

Matched citations: S. 1399

H.R. 6197119th Congress

Health Tech Investment Act

2025 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care and treatment, medical device remanufacturing, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 6197

S. 1399119th Congress

Health Tech Investment Act

2025 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care and treatment, medical device remanufacturing, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 1399

S. 1399119th Congress

Health Tech Investment Act

2025 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to cancer care and treatment, medical device remanufacturing, and artificial intelligence use in health care including S. 1399 - Health Tech Investment Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 1399

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: S. 1544

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1199/ S. 1544 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1199/ S. 1544 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: S. 1544

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1199/ S. 1544 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1199/ S. 1544 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: S. 1544

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1199/ S. 1544 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2024 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 1199/ S. 1544 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: S. 1544

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: S. 1544

H.R. 1199118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1199

S. 1544118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

2023 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.

Client expense: — · Firm income: $60,000

Matched citations: S. 1544

H.R. 4479117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 4479

S. 2609117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing.

Client expense: — · Firm income: $60,000

Matched citations: S. 2609

H.R. 4479117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 4479

S. 2609117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

2022 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.

Client expense: — · Firm income: $60,000

Matched citations: S. 2609

Source: Senate LDA

SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) — Lobbying Disclosure | Poliscope